E-ISSN 0976-2779 | ISSN 0975-8453
 

Review Article 


Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders

Asmaa Mohammed Saud.

Abstract
Epileptic seizures lead to changes in the importance of the blood laboratory tests which represent changes in various systems of organs in the body. A present study assessed the association between the rs3812718 polymorphism in SCN1A gene and susceptibility with epilepsy. In total, 48 subjects (28 patients and 20 controls) were included in the study. Subjects’ age and sex were matched. The patients' demographic profiles, including the gender (female: 26 and male; 34), mean of ages (21±8.6), the controls gender (female: 6 and male; 19) and age mean (39±13.3). Single nucleotide polymorphisms (SNPs) was used to investigate the distribution of SCN1A rs3812718 genotypes (G > A) in patients with Epilepsy. Direct sequencing is use to identify the (G>A) polymorphisms of the SCN1A gene on chromosome 2q24. Genotypes and allelic frequencies for the SCN1A in both groups were compared. In addition, the results show two other SNPs for the first time in Iraqi patients rs2217199 T>C and rs3812719 G>T and the study determines some biochemical tests (potassium) were performed by Reflotron and (glucose, sodium, chloride and calcium) by a Spectrophotometer in the sera of subjects. In this population, the alleles frequency of rs2217199/ C, rs3812719/ T, rs3812718/A, the susceptibility of epileptic with gene polymorphisms was correlated (OR = 5.84, p = 0.0001; OR = 4.41, p = 0.001; OR = 5.33, p = 0.001; respectively). The haplotype (CTA) was also significantly related with Epileptic patients (OR = 7.08; p = 0.001). Also, the study showed an increase in glucose levels at p-value= 0.008, normal value in serum K, Cl, Ca and Na levels in Epileptic patient with seizure compare with control. The study in an Iraqi population suggests that SCN1A polymorphisms genetic risk factor for Epileptic patients. Simple blood testing, particularly for some encephalopathies, can be a crucial help for recognizing the etiology.

Key words: Epileptic seizures, Single nucleotide polymorphisms (SNPs), SCN1A, Haplotype.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Asmaa Mohammed Saud
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Asmaa Mohammed Saud. Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . SRP. 2021; 12(2): 119-126. doi:10.31838/srp.2021.2.11


Web Style

Asmaa Mohammed Saud. Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . http://www.sysrevpharm.org/?mno=10117 [Access: January 18, 2021]. doi:10.31838/srp.2021.2.11


AMA (American Medical Association) Style

Asmaa Mohammed Saud. Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . SRP. 2021; 12(2): 119-126. doi:10.31838/srp.2021.2.11



Vancouver/ICMJE Style

Asmaa Mohammed Saud. Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . SRP. (2021), [cited January 18, 2021]; 12(2): 119-126. doi:10.31838/srp.2021.2.11



Harvard Style

Asmaa Mohammed Saud (2021) Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . SRP, 12 (2), 119-126. doi:10.31838/srp.2021.2.11



Turabian Style

Asmaa Mohammed Saud. 2021. Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . Systematic Reviews in Pharmacy, 12 (2), 119-126. doi:10.31838/srp.2021.2.11



Chicago Style

Asmaa Mohammed Saud. "Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders ." Systematic Reviews in Pharmacy 12 (2021), 119-126. doi:10.31838/srp.2021.2.11



MLA (The Modern Language Association) Style

Asmaa Mohammed Saud. "Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders ." Systematic Reviews in Pharmacy 12.2 (2021), 119-126. Print. doi:10.31838/srp.2021.2.11



APA (American Psychological Association) Style

Asmaa Mohammed Saud (2021) Analysis of SCN1A polymorphism as Genetic Risk Factor for Neurological Disorders . Systematic Reviews in Pharmacy, 12 (2), 119-126. doi:10.31838/srp.2021.2.11





Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study
    Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli
    SRP. 2020; 11(1): 01-06
    » Abstract » doi: 10.5530/srp.2020.1.01

  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context
    Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran
    SRP. 2020; 11(1): 14-22
    » Abstract » doi: 10.5530/srp.2020.1.03

  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata
    Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi
    SRP. 2019; 10(1): 15-19
    » Abstract » doi: 10.5530/srp.2019.1.3

  • A Review of Pharmacoeconomics: the key to “Healthcare for All”
    Hasamnis AA, Patil SS, Shaik Imam, Narendiran K
    SRP. 2019; 10(1): s40-s42
    » Abstract » doi: 10.5530/srp.2019.1s.21

  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer
    Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova
    SRP. 2019; 10(1): 112-117
    » Abstract » doi: 10.5530/srp.2019.1.19

  • Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study
    Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli
    SRP. 2020; 11(1): 01-06
    » Abstract » doi: 10.5530/srp.2020.1.01

  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review
    Karle Pravin P, Dhawale Shashikant C
    SRP. 2019; 10(1): 11-14
    » Abstract » doi: 0.5530/srp.2019.1.2

  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba
    Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar
    SRP. 2019; 10(1): 20-25
    » Abstract » doi: 10.5530/srp.2019.1.4

  • A Review of Pharmacoeconomics: the key to “Healthcare for All”
    Hasamnis AA, Patil SS, Shaik Imam, Narendiran K
    SRP. 2019; 10(1): s40-s42
    » Abstract » doi: 10.5530/srp.2019.1s.21

  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context
    Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran
    SRP. 2020; 11(1): 14-22
    » Abstract » doi: 10.5530/srp.2020.1.03

  • Most Cited Articles